Determination of Fluoxetine and Norfluoxetine in Human Serum and Urine by HPLC Using a Cholester Column with Fluorescence Detection

Journal of Liquid Chromatography and Related Technologies

Volumn 32, Issue 8, 2009, Pages 1141-1151

  Higashi, Yasuhiko ^a   Gao, Ranzhi ^a   Fujii, Youichi ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

Cholester column; Derivatization; Fluoxetine; Norfluoxetine 4 fluoro 7 nitro 2,1,3 benzoxadiazole

Indexed keywords

BORATE BUFFER; CHOLESTER COLUMN; COEFFICIENTS OF VARIATIONS; DERIVATIZATION; DETECTION LIMITS; FLUORESCENCE DETECTION; FLUOXETINE; HPLC-FLUORESCENCE DETECTION; HUMAN SERUM; HUMAN URINE; INTERNAL STANDARDS; NORFLUOXETINE; NORFLUOXETINE 4-FLUORO-7-NITRO-2,1,3-BENZOXADIAZOLE; PRECOLUMN DERIVATIZATION; REGRESSION EQUATION; SAMPLE VOLUME; SELECTIVE SEROTONIN REUPTAKE INHIBITOR; THERAPEUTIC DRUG MONITORING;

EXTRACTION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; PARAFFINS; PATIENT MONITORING; POLYMORPHISM;

BODY FLUIDS;

4 FLUORO 7 NITRO 2,1,3 BENZOXADIAZOLE; BORIC ACID; FLUOXETINE; NORFLUOXETINE; PENTANE; PROTRIPTYLINE; REAGENT; UNCLASSIFIED DRUG;

ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DERIVATIZATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; DRUG URINE LEVEL; EXTRACTION; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PH;

EID: 67651235259     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826070902841844     Document Type: Article

References (21)

1. Schmidt, M.J.; Fuller, R.W.; Wong, D.T. Fluoxetine, a highly selective serotonin reuptake inhibitor: a review of preclinical studies. Br. J. Psychiat. Suppl. 1988, 3, 40-46.
2. Lemberger, L.; Rowe, H.; Carmichael, R.; Crabtree, R.; Horng, J.S.; Bymaster, F.; Wong, D. Fluoxetine, a selective serotonin uptake inhibitor. Clin. Pharmacol. Ther. 1978, 23, 421-429.
3. Wong, D.T.; Bymaster, F.P.; Reid, L.R.; Mayle, D.A.; Krushinski, J.H.; Robertson, D.W. Norfluoxetine enantiomers as inhibitors of serotonin uptake in rat brain. Neuropsychopharmacology. 1993, 8, 337-344.
4. Baumann, P. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors. Clin. Pharmacokinet. 1996, 31, 444-469.
5. Unceta, N.; Gómez-Caballero, A.; Sánchez, A.; Millán, S.; Sampedro, M.C.; Goicolea, M.A.; Salles, J.; Barrio, R.J. Simultaneous determination of citalopram, fluoxetine and their main metabolites in human urine samples by solid-phase microextraction coupled with high-performance liquid chromatography. J. Pharm. Biomed. Anal. 2008, 46, 763-770.
6. Altamura, A.C.; Moro, A.R.; Percudani, M. Clinical pharmacokinetics of fluoxetine. Clin. Pharmacokinet. 1994, 26, 201-214.
7. Cruz-Vera, M.; Lucena, R.; Cárdenas, S.; Valcárcel, M. Combined use of carbon nanotubes and ionic liquid to improve the determination of antidepressants in urine samples by liquid chromatography. Anal. Bioanal. Chem. 2008, 391, 1139-1145.
8. Malfará, W.R.; Bertucci, C; Costa Queiroz, M.E.; Dreossi Carvalho, S.A.; Pires Bianchi Mde, L.; Cesarino, E.J.; Crippa, J.A.; Costa Queiroz, R.H. Reliable HPLC method for therapeutic drug monitoring of frequently prescribed tricyclic and nontricyclic antidepressants. J. Pharm. Biomed. Anal. 2007, 44, 955-962.
9. Suckow, R.F.; Zhang, M.F.; Cooper, T.B. Sensitive and selective liquidchromatographic assay of fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization. Clin. Chem. 1992, 38, 1756-1761.
10. Kovacevic, I.; Pokrajac, M.; Miljkovic, B.; Jovanovic, D.; Prostran, M. Comparison of liquid chromatography with fluorescence detection to liquid chromatography-mass spectrometry for the determination of fluoxetine and norfluoxetine in human plasma. J. Chromatogr. B. 2006, 830, 372-376.
11. Santos-Neto, A.J.; Bergquist, J.; Lancas, F.M.; Sjoberg, P.J. Simultaneous analysis of five. Antidepressant drugs using direct injection of biofluids in a capillary restricted-access media-liquid chromatography-tandem mass spectrometry system. J. Chromatogr. A. 2008, 1189, 514-522.
12. Juan, H.; Zhiling, Z.; Huande, L. Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI). J. Chromatogr. B. 2005, 820, 33-39.
13. Lantz, R.J.; Farid, K.Z.; Koons, J.; Tenbarge, J.B.; Bopp, R.J. Determination of fluoxetine and norfluoxetine in human plasma by capillary gas chromatography with electron-capture detection. J. Chromatogr. 1993, 614, 175-179.
14. Martínez, M.A.; Sánchez de la Torre, C; Almarza, E. A comparative solidphase extraction study for the simultaneous determination of fluoxetine, amitriptyline, nortriptyline, trimipramine, maprotiline, clomipramine, and trazodone in whole blood by capillary gas-liquid chromatography with nitrogen-phosphorus detection. J. Anal. Toxicol. 2003, 27, 353-358.
15. Berzas Nevado, J.J.; Villaseñor Llerena, M.J.; Guiberteau Cabanillas, C; Rodríguez Robledo, V. Screening of citalopram, fluoxetine and their metabolites in human urine samples by gas chromatography-mass spectrometry. A global robustness/ruggedness study. J. Chromatogr. A. 2006, 1123, 130-131.
16. Nerzas Nevado, J.J.; Villaseñor Llerena, M.J.; Guiberteau Cabanillas, C; Rodríguez Robledo, V.; Buitrago, S. Sensitive capillary GC-MS-SIM determination of selective serotonin reuptake inhibitors: reliability evaluation by validation and robustness study. J. Sep. Sci. 2006, 29, 103-113.
17. Clausing, P.; Rushing, L.G.; Newport, G.D.; Bowyer, J.F. Determination of D-fenfluramine, D-norfenfluramine and fluoxetine in plasma, brain tissue and brain microdialysate using high-performance liquid chromatography after precolumn derivatization with dansyl chloride. J. Chromatogr. B. 1997, 692, 419-426.
18. Guo, X.; Fukushima, T.; Li, F.; Imai, K. Determination of fluoxetine and norfluoxetine in rat plasma by HPLC with pre-column derivatization and fluorescence detection. Biomed. Chromatogr. 2003, 17, 1-5.
19. Ertürk, S.; Cetin, S.M.; Atmaca, S.; Ersoy, L.; Baktr, G. A sensitive HPLC method for the determination of fluoxetine and norfluoxetine in human plasma with fluorescence detection. Ther. Drug Monit. 2005, 27, 38-43.
20. Karnes, H.T.; Shiu, G.; Shah, V.P. Validation of bioanalytical methods. Pharm. Res. 1991, 8, 421-426.
21. Shah, V.P.; Midha, K.K.; Findlay, J.W.; Hill, H.M.; Hulse, J.D.; McGilveray, I.J.; McKay, G.; Miller, K.J.; Patnaik, R.N.; Powell, M.L.; Tonelli, A.; Viswanathan, C.T.; Yacobi, A. Bioanalytical method validationa revisit with a decade of progress. Pharm. Res. 2000, 17, 1551-1557.